NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Drug Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Apoptosis



Studies advance knowledge in apoptosis research



November 18th, 2005

Apoptosis research advances have been reported from Turkey, Taiwan and the United States.

Study 1: Researchers explored the effects of diethylstilbestrol in human lymphocytes in vitro.

"Most of the biological, chemical or physical agents that cause cell death in certain doses and time of exposure may induce either apoptosis or necrosis. This study explores in what ways the genotoxic, cytotoxic and apoptotic effects of diethylstilbestrol (DES), a chemical agent currently used in the treatment of various types of cancer, on the human lymphocytes depend upon the dose and the exposure time," scientists writing in the journal Molecular and Cellular...


Source: Drug Week (2005-11-18)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login